HYPR
Price
$0.68Alerts
Change
-$0.03 (-4.23%)
Updated
Nov 12 closing price
Capitalization
76.3M
131 days until earnings call
Intraday BUY SELL Signals
TMCI
Price
$5.34Alerts
Change
+$0.28 (+5.53%)
Updated
Nov 12 closing price
Capitalization
262.09M
111 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HYPR vs TMCI

HYPR vs TMCI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HYPR vs. TMCI commentary
Nov 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HYPR is a Hold and TMCI is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for HYPR with price predictions
Nov 12, 2026

HYPR's Stochastic Oscillator remains in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +8.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where HYPR advanced for three days, in 181 of 220 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HYPR as a result. In 84 of 103 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

The Moving Average Convergence Divergence Histogram (MACD) for HYPR turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 43 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.

HYPR moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for HYPR crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HYPR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

HYPR broke above its upper Bollinger Band on October 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for HYPR entered a downward trend on November 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.076) is normal, around the industry mean (4.142). P/E Ratio (-1.945) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (4.340) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. HYPR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HYPR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for TMCI with price predictions
Nov 12, 2026

TMCI in upward trend: 10-day moving average crossed above 50-day moving average on November 02, 2026

The 10-day moving average for TMCI crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on TMCI as a result. In 73 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.

The Moving Average Convergence Divergence (MACD) for TMCI just turned positive on November 09, 2026. Looking at past instances where TMCI's MACD turned positive, the stock continued to rise in 31 of 43 cases over the following month. The odds of a continued upward trend are 72%.

TMCI moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +9.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where TMCI advanced for three days, in 204 of 266 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

The Aroon Indicator entered an Uptrend today. In 127 of 162 cases where TMCI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.

Bearish Trend Analysis

The 10-day RSI Indicator for TMCI moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 20 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMCI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

TMCI broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.869) is normal, around the industry mean (4.142). P/E Ratio (-4.380) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.430) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. TMCI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TMCI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
HYPRTMCI
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 17 days ago
82%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
COMPARISON
Comparison
Nov 13, 2026
Stock price -- (HYPR: $0.68 vs. TMCI: $5.34)
Brand notoriety: HYPR and TMCI are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: HYPR: 64% vs. TMCI: 123%
Market capitalization -- HYPR: $76.3M vs. TMCI: $262.09M
HYPR [@Medical/Nursing Services] is valued at $76.3M. TMCI’s [@Medical/Nursing Services] market capitalization is $262.09M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HYPR’s FA Score shows that 1 FA rating(s) are green while TMCI’s FA Score has 1 green FA rating(s).

  • HYPR’s FA Score: 1 green, 4 red.
  • TMCI’s FA Score: 1 green, 4 red.
According to our system of comparison, TMCI is a better buy in the long-term than HYPR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HYPR’s TA Score shows that 2 TA indicator(s) are bullish while TMCI’s TA Score has 6 bullish TA indicator(s).

  • HYPR’s TA Score: 2 bullish, 7 bearish.
  • TMCI’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TMCI is a better buy in the short-term than HYPR.

Price Growth

HYPR (@Medical/Nursing Services) experienced а -0.89% price change this week, while TMCI (@Medical/Nursing Services) price change was +27.75% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.08%. For the same industry, the average monthly price growth was -5.52%, and the average quarterly price growth was -4.54%.

Reported Earning Dates

HYPR is expected to report earnings on Mar 24, 2027.

TMCI is expected to report earnings on Mar 04, 2027.

Industries' Descriptions

@Medical/Nursing Services (+2.08% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

HYPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, HYPR has been loosely correlated with BFLY. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if HYPR jumps, then BFLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPR
1D Price
Change %
HYPR100%
-4.50%
BFLY - HYPR
40%
Loosely correlated
-6.58%
QSI - HYPR
33%
Loosely correlated
-3.94%
SGHT - HYPR
33%
Loosely correlated
+0.64%
CLPT - HYPR
30%
Poorly correlated
-7.42%
TMCI - HYPR
28%
Poorly correlated
+5.53%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FMAY57.12-0.16
-0.28%
FT Vest U.S. Equity Buffer Fund - May (FMAY)
PSQO20.67-0.06
-0.28%
Palmer Square Credit Opportunities ETF
FCFY31.14-0.13
-0.42%
First Trust S&P 500 Diversified Free Cash Flow ETF (FCFY)
PSCD116.18-2.34
-1.97%
Invesco S&P SmallCap Consumer Discretionary ETF (PSCD)
XXRP15.68-1.00
-6.00%
Teucrium 2X Long Daily Xrp ETF